Ivana 150 mg (Tablet)
1 tablet kit: ৳ 995.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Ibandronic acid |
| Company | Renata limited |
Title
- Ivana 150 mg Film-Coated Tablet
Categories
- Medicine
- Osteoporosis Treatment
Description
- Indicated for the treatment and prevention of osteoporosis in postmenopausal women and men
- Inhibits bone resorption and increases bone mass
- Recommended monthly dosage of one 150 mg tablet
- Interacts with calcium supplements, antacids, and multivalent cation-containing medications
- Contraindicated in patients with hypersensitivity to ibandronic acid
- Common side effects include dyspepsia, nausea, and abdominal pain
- Not to be used during pregnancy or lactation
- Precautions for hypocalcemia and upper gastrointestinal problems
- No dosage adjustment needed for renal or hepatic impairment
- Storage condition: below 30°C temperature, away from light & moisture
Dimensions
6.5mm x 6.5mm x 3mm
Color Options
- White
Function
- Treatment of osteoporosis
- Prevention of osteoporosis
- Inhibition of bone resorption
- Increased bone mass
Material
- Bisphosphonate preparations
Technical Specifications
- Dosage: 150 mg film-coated tablet
- Administration: Once a month, 60 minutes before the first meal or drink
- Interaction: Wait 60 minutes before taking other oral medications
- Overdose Effects: May result in upper gastrointestinal adverse events
Design Elements
Usability Features
- Dosage & Administration Instructions:
- Swallow whole with plain water while sitting or standing upright
- Do not lie down for 60 minutes after taking
- Storage: Keep out of the reach of children
Indications
- Treatment and prevention of osteoporosis in postmenopausal women
- Prevention and treatment of osteoporosis in men
Pharmacology
- Inhibition of bone resorption
- Highly potent inhibitor of osteoclastic activity
- Reduces bone resorption without interfering with bone formation
Interaction
- Avoid concurrent intake of calcium supplements, antacids, and certain oral medications
Contraindications
- Hypersensitivity to ibandronic acid
- Uncorrected hypocalcemia
- Abnormalities of the esophagus
- Inability to stand or sit upright for at least 60 minutes
Side Effects
- Dyspepsia
- Nausea
- Abdominal pain
- Muscle aches
- Headaches
- Dizziness
Pregnancy & Lactation
- Not recommended during pregnancy
- Not to be used during lactation
Precautions & Warnings
- Effective treatment of hypocalcemia and other bone/mineral metabolism disturbances prior to therapy
- Caution in patients with active upper gastrointestinal problems
- Alert for signs of possible esophageal reaction and discontinuation instructions
- Risk of osteonecrosis of the jaw
Use in Special Populations
- Renal Impairment: No dosage adjustment for mild or moderate impairment
- Hepatic Impairment: No dosage adjustment needed
- Elderly: No dosage adjustment needed
- Children: Safety and efficacy not established in patients less than 18 years old
Overdose Effects
- Symptoms: Upper gastrointestinal adverse events
- Treatment:
- Milk or antacids to bind ibandronic acid
- No induction of vomiting
Therapeutic Class
Bisphosphonate preparations
Storage Conditions
Below 30°C temperature, away from light & moisture, keep out of the reach of children